Xvivo Perfusion AB (publ) XVIVO

Updated: 9 Sep 2026

Stockholm | Biotech | Organ transplantation and medical technology

No signal published yet

We already track Xvivo Perfusion and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Xvivo Perfusion free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
Stockholm
Type
Biotech
Sector
Organ transplantation and medical technology
We're already tracking Xvivo Perfusion AB (publ) — here are the latest events we've registered

Recent News

  • On August 11, 2026, XVIVO received CE mark approval in Europe for its XVIVO Heart Assist Transport system. The approval enables immediate clinical use of the company's heart preservation technology across European transplant centers.

What Firelda Watch includes for Xvivo Perfusion AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Xvivo Perfusion AB (publ) will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Getinge
GETI B
HOLD
Surgical Science Sweden AB (publ)
SUS
HOLD
Vitrolife AB (publ)
VITR
HOLD
Vimian Group AB (publ)
VIMIAN
HOLD
CellaVision AB (publ)
CEVI
HOLD

Biotech

More companies in this sector

Want to follow Xvivo Perfusion AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Xvivo Perfusion free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Xvivo Perfusion AB (publ) XVIVO
Xvivo Perfusion — follow and we'll monitor it
Follow Xvivo Perfusion free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.